Emory University School of Medicine
Martin G. Sanda, MD, is Professor and Chair of Urology at Emory University School of Medicine and Director of the Prostate Cancer Center at Emory’s Winship Cancer Institute. Dr. Sanda’s clinical expertise focuses on prostate cancer multidisciplinary care, active surveillance, and robotic prostatectomy, while his academic expertise focuses on prostate cancer immunology, biomarker, and patient-reported outcomes research. He has held continuous NIH funding for over 20 years as Principal Investigator of studies evaluating prostate cancer detection, immunotherapy and quality of life that have led to more than 150 publications which have been cited over 10,000 times in the biomedical literature. Dr. Sanda is Chair of the AUA-SUO-ASTRO Committee on Localized Prostate Cancer Treatment Guidelines, and has served as Chair of the Prostate Cancer Collaborative Group of the National Cancer Institute’s Early Detection Research Network.
After receiving his BA in Molecular Biophysics and Biochemistry from Yale University in 1983, Dr. Sanda completed his MD degree at Columbia University, trained as a general surgery resident at the Medical College of Virginia and surgical oncology fellow at the National Cancer Institute before completing his urology residency at Johns Hopkins Hospital. Dr. Sanda served on the faculty at the University of Michigan from 1995-2003, where he attained tenure as Associate Professor before moving to Harvard in 2003, where he rose to the position of Professor of Urology at Harvard Medical School and Beth Israel Deaconess Medical Center, before assuming his current position at Emory in 2013.
Monday, May 6
10:10 AM – 10:30 AM